Search Results
Nov 03, 2025, 06:20 ET Events Industry Market to Reach $2.5 trillion, Globally, by 2035 at 6.8% CAGR: Allied Market Research
Membership Fees, Participation Fees, Media and Licensing Revenue, and Others), Organizer (Corporate, Sports, Education, Entertainment, and Others), Age Group (Below 20 Years, 21 to 40 Years, and Above 40 Years), Origin of Attendees (National, Continental, and Transcontinental), and Event Location (Tier
More news about: Allied Market Research
Nov 03, 2025, 06:17 ET TCT 2025 | Robot-Assisted PCI Enters a New Era: Results of the PANVIS STAR Multicenter Randomized Controlled Trial
results showed:Robotic group: 71 cases; Conventional manual group: 73 cases. There were no significant differences between the two groups in age, gender, underlying diseases (hypertension, hyperlipidemia, diabetes), or clinical diagnosis at admission.Interventional process and angiographic
More news about: Shenzhen Institute of Advanced Biomedical Robot Co., Ltd. (abrobo)
Nov 03, 2025, 03:30 ET FAMEL debuts at EICMA
modern electric engineering. Powered by a 5.5 kW motor and offering up to 120 km of range, the E-XF brings classic café-racer style into the electric age. The starting price of around €7,000 offers an accessible entry point into European-built performance (Hall7, Booth A14). The
More news about: FAMEL
Nov 03, 2025, 03:30 ET FAMEL debuts at EICMA
modern electric engineering. Powered by a 5.5 kW motor and offering up to 120 km of range, the E-XF brings classic café-racer style into the electric age. The starting price of around €7,000 offers an accessible entry point into European-built performance (Hall7, Booth A14). The
More news about: FAMEL
Nov 01, 2025, 18:24 ET CopperSmith® and Kate Smith Unveil French Country Kitchen Transformation
completely personal."The transformation goes along with a broader industry trend: homeowners are investing in custom statement pieces that age gracefully with their homes. The National Kitchen & Bath Association reports that kitchen remodeling is the leading segment of the $522 billion U.S.
More news about: World CopperSmith, Inc
Nov 01, 2025, 05:02 ET LUNGevity Foundation Leads 2025 Lung Cancer Awareness Month to Drive Research, Awareness, and Early Detection
encouraging action with its signature "Anyone with Lungs Can Get Lung Cancer" campaign, emphasizing that lung cancer does not discriminate by age, gender, or smoking history, and give the public action items to spread the word. An installation
More news about: LUNGevity Foundation
Nov 01, 2025, 03:00 ET Two Billion Live with Vision Impairment -- Can AI Help Prevent Sight Loss?
medical specialty, accounting for nearly 10% of all NHS appointments—about 10 million annually—up by more than a third in five years. He highlights age-related macular degeneration (AMD) as a leading cause of blindness, with ~25% of Europeans over 60 showing early signs and ~400 people in the UK developing
More news about: Planet Classroom Network
Oct 31, 2025, 20:33 ET After-School Education Franchise COMPUCHILD Expands Into the Cities of Castro Valley and San Leandro, in California
curricula, COMPUCHILD's after-school programs are already leading the way. Its innovative STEM courses introduce AI concepts in fun, accessible, and age-appropriate ways, helping students develop the awareness and adaptability they will need in an AI-driven world. For those who
More news about: CompuChild
Oct 31, 2025, 16:33 ET Buchanan Celebrates 175th Anniversary
Washington, DC. Continuing its success, the firm added its Chicago office in 2025. To fully harness the power of today's digital age and bring value to clients, the firm marked a new milestone in its history with the launch of
More news about: Buchanan Ingersoll & Rooney PC
Oct 31, 2025, 14:15 ET Resume.org Survey: Nearly Half of Workers Won't Get a Raise in 2025
U.S. business leaders. To qualify, respondents had to meet strict demographic criteria, including education (college or higher), income ($75,000+), age (30+), and full-time employment. Full report:
More news about: Resume.org
Oct 31, 2025, 13:04 ET BIMZELX® (bimekizumab-bkzx) Data in Hidradenitis Suppurativa Showed Improvements in Pain and Resolution of Draining Tunnels Sustained to Three Years
signs and symptoms occurs. ImmunizationsPrior to initiating therapy with BIMZELX, complete all age-appropriate vaccinations according to current immunization guidelines. Avoid the use of live vaccines in patients treated with BIMZELX.
More news about: UCB
Oct 31, 2025, 12:00 ET Costway Launches 2025 Black Friday with Torch Hunt Challenges, Cashback Rewards, and Unprecedented Discounts
interaction adds a spark to the great Black Friday Castle, with customers getting a chance to win exclusive rewards through participation and excitement. All age shoppers are welcome to join in, complete simple tasks, and track their progress as the castle lights up step by step.
More news about: Costway
Oct 31, 2025, 09:50 ET Springer Nature honours Indian editors at Journal Development Symposium 2025. Brings Together Leading Editors and Publishing Experts to Shape the Future of Research Integrity and AI in Scholarly Communication
journal editors, society representatives, and publishing professionals from across India to discuss the evolving dynamics of research publishing in the age of Artificial Intelligence (AI) and Open Access.
More news about: Springer Nature
Oct 31, 2025, 09:08 ET Stablecoins New Era Begins: Inside the Next Wave of Institutional Adoption and Infrastructure Competition
implementation of key frameworks, such as the GENIUS Act, Stablecoin Ordinance, and MiCA, has initiated what the report identifies as the "Age of Compliance." The report also highlights the growing participation of major financial institutions including PayPal, Visa,
More news about: Alchemy Pay
Oct 31, 2025, 09:00 ET Zhimeng Biopharma's investigational drug CB03-154 for amyotrophic lateral sclerosis has achieved the first patient first dose milestone in the phase 2/3 pivotal clinical trial.
respiratory failure. The annual incidence of ALS in Europe and the United States is 2/100,000 to 3/100,000, and the prevalence rate is 3-5/100,000. The peak age of onset is 50 to 75 years. Approximately 10% of ALS patients are familial, while the remaining 90% are sporadic. Currently, there are no treatments
More news about: Shanghai Zhimeng Biopharma Inc.
Oct 31, 2025, 09:00 ET Spread Your Wings: Applications open tomorrow for seventh edition of the Air Canada and CAE Captain Judy Cameron Scholarship
About Judy CameronJudy Cameron became the first female pilot hired by Air Canada, Canada's largest airline, in April 1978 at the age of 23. She was the first woman to graduate from Selkirk College's Aviation Technology Program in 1975. Throughout her flying career of 40 years and over
More news about: CAE Inc.
Oct 31, 2025, 08:31 ET Experience the Rhythm of November at Jimmy's Jazz & Blues Club
— Sunday, November 9, 2025: Celebrate the golden age of British rock with spot-on renditions of The Beatles, The Stones, The Who, and more.
More news about: Jimmy's Jazz & Blues Club
Oct 31, 2025, 08:00 ET Servier's VORANIGO® (vorasidenib) Receives Prestigious 2025 Prix Galien USA Award
What is VORANIGO? VORANIGO (40 mg tablets) is a prescription medicine used to treat adults and children 12 years of age and older with certain types of brain tumors called astrocytoma or oligodendroglioma with an isocitrate dehydrogenase-1 (IDH1) or isocitrate dehydrogenase-2
More news about: Servier Pharmaceuticals
Oct 31, 2025, 06:46 ET GITEX GLOBAL 2025: Record international participation and outcome-driven dialogues close landmark 45th edition
Europe, Asia, the Middle East, and Latin America tackled the questions of trust, regulation, and sovereignty in the age of AI – from designing autonomous systems to defending against quantum-age threats and securing cross-border data flows. Their exchanges signalled a global turning point: nations are no
More news about: GITEX
Oct 31, 2025, 06:44 ET GITEX GLOBAL 2025: Record international participation and outcome-driven dialogues close landmark 45th edition
Europe, Asia, the Middle East, and Latin America tackled the questions of trust, regulation, and sovereignty in the age of AI – from designing autonomous systems to defending against quantum-age threats and securing cross-border data flows. Their exchanges signalled a global turning point: nations are no
More news about: GITEX
Oct 31, 2025, 06:22 ET Weekly Recap: 13 Health Press Releases You Need to See
This acquisition aligns Lilly's genetic medicine capabilities with the opportunity to expand gene therapy's potential to alleviate the burden of age-related diseases.
More news about: PR Newswire
Oct 31, 2025, 04:00 ET Vesper Bio announces positive Phase Ib/IIa topline results for lead candidate VES001 for frontotemporal degeneration
behaviour, judgement, communication and ability to participate in all activities of daily living. It is the most common cause of dementia in people under the age of 60 and is often misdiagnosed as Alzheimer's disease. FTD-GRN is a form of FTD caused by mutations of the progranulin gene (GRN), resulting in low
More news about: Vesper Bio
Oct 30, 2025, 17:40 ET S4 Capital's Monks Launches White Paper "Owning the Answer: The Marketer's Playbook for AEO, GEO and the AI Search Era"
these local market trends and learnings with a global view, taking into account learnings for brands at the global scale. "In the age of unified growth, our focus must always be on what drives maximum client value and competitive advantage," said Sir Martin Sorrell, Founder and Executive
More news about: Monks
Oct 30, 2025, 17:31 ET Atypical Teratoid/Rhabdoid Tumor Treatment Market Shows Promising CAGR During the Forecast Period (2025-2034) with Growing Clinical Trials and R&D Initiatives | DelveInsight
of Atypical Teratoid/Rhabdoid Tumor Gender-specific Cases of Atypical Teratoid/Rhabdoid Tumor Age-specific Cases of Atypical Teratoid/Rhabdoid Tumor Total Treatable Cases of Atypical Teratoid/Rhabdoid Tumor
More news about: DelveInsight Business Research, LLP
Oct 30, 2025, 16:30 ET Continued Year-over-year Margin Expansion and Improved Cash Flow Highlight Cooper Standard's Third Quarter Results
forecasts, the Company believes that the underlying demand for new light vehicle production in its key operating regions remains strong, supported by the age of the existing fleet, increasing population, increasing numbers of newly licensed drivers, and declining vehicle inventories. The Company remains confident
More news about: Cooper Standard